Sabinsa’s Boswellin® super reported In japanese study to show improvement in knee pain
A study evaluating the effects of Sabinsa’s Boswellin® Super (BSR) on knee pain reduction was recently published in the European Journal of Biomedical and Pharmaceutical Sciences…
European journal publishes article on Sami/Sabinsa oil control moisturizer safety and efficacy
A study on an oil control moisturize developed by Sami / Sabinsa was recently published; An open label clinical study to evaluate the dermal safety ad post-application effect of an oil control moisturizer…
US district court holds Aegle Bios liable for willful infringement of Sabinsa’s Tetrahydrocurcuminoid patent
Sabinsa Corp. has again prevailed in legal action protecting one of the company’s patent, this time in a law suit filed against Aegle Bios Inc. (Edison, NJ) for willful patent infringement on June 8, 2016…
Sabinsa’s VP scientific affairs Anurag Pande Ph.D. speaks at Nutraceutical and Functional Food Summit in Beijing
Sabinsa’s Vice President of Scientific Affairs, Anurag Pande PhD, will moderate and speak on a panel at the 6th China International Nutraceutical and Functional Food Summit 2016, held on November 15th–17th2016 in Beijing Crowne Plaza…
Nachurel ingredients agrees to consent judgment honoring Sabinsa’s Tetrahydrocurcuminoids patent
Nachurel Ingredients LLC(North Brunswick, NJ) has agreed to a Final Consent Judgment that resolves a previous lawsuit for infringement of Sabinsa’s U.S. Patent No. 6,653,327, covering compositions and uses of turmeric-derived Tetrahydrocurcuminoids…
Sabinsa’s Curcumin C3 Complex® in combination with Omega-3s found to have synergistic effect
Sabinsa’s Curcumin C3 Complex® has been found by researchers in several studies to be an excellent complementary supplement to Omega-3 fatty acids. While curcumin is a well recognized anti-inflammatory agent, Omega-3 acids…
Sabinsa on Wheels science summit In Tokyo
Sabinsa Japan Corporation will host Sabinsa on Wheels, a day-long science summit for customers, on October 21, 2016 at the Shangri-La Hotel in Tokyo, Japan. The topics presented by a range of speakers will include the latest clinical studies…
Sabinsa’s VP scientific affairs Dr. Anurag Pande to present On LactoSpore® At 4th microbiome R&D and business collaboration forum
Sabinsa’s VP Scientific Affairs Anurag Pande PhD will give a presentation addressing the recent safety and efficacy studies on Sabinsa’s shelf-stable probiotic LactoSpore® at the Global Engage 4th Microbiome R&D…
Sabinsa again honored with two pharmexcil awards noting excellence in patents and exports
Sabinsa Corporation’s parent company Sami Labs was recently honored with two Pharmexcil Awards for 2015 – 2016 in the Herbals category: the Silver Award for Patents and the Outstanding Export Performance Award…
Sabinsa to highlight recent published studies, new canadian health claims at Supplyside West
Throughout 2016 a number of clinical studies have been published on ingredients developed by Sabinsa Corporation, and many of those will be highlighted in the company’s booth, # Y135, at SupplySide West, October 6 –7, 2016 in Las Vegas, NV…
Sabinsa and Chemill Reach licensing agreement Sabinsa’s Tetrahydrocurcuminoids patent honored
Sabinsa Corp. and Chemill Inc. (Bothell, WA) have reached an agreement which resolves a previous lawsuit for infringement of Sabinsa’s U.S. Patent No. 6,653,327, covering compositions and uses of turmeric-derived tetrahydrocurcuminoids…
Sabinsa receives approval for New Health Claims on Curcumin C3 Complex® and Curcumin C3 Reduct® in Canada
Sabinsa’s Curcumin C3 Complex® and Curcumin C3 Reduct® received two significant health claims from Health Canada based on the new clinical studies on the respective products…
Sabinsa corporation defends proprietary distinctiveness in Its brand “Boswellin”
In line with its commitment to enforce intellectual property and to honour the trust of millions of customers vested in its branded ingredients, Sabinsa Corporation successfully defended its proprietary rights on European Union Community trademark. 000379743 for “Boswellin” in international class 05…
Sabinsa achieves significant canadian health claim on IBS for shelf stable probiotic LactoSpore®
Health Canada, the federal department that regulates the products that help the people of Canada maintain and improve their health, has issued a Product License to Sabinsa for a significant health claim…
Sami-Sabinsa recognized by Global Health & Pharma as the “BEST International Life Science Company” and “Most Innovative Inflammatory Condition Treatment”
Sami-Sabinsa, a research oriented Indian multinational health science company and a leading producer of nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals and probiotics…
Sabinsa’s parent company Sami Labs recognized for excellence in research and development
Sabinsa’s parent company Sami Labs Ltd. was recently honored with the DC Media Kerala MSME Excellence In Research and Development Award in conjunction with an event highlighting the growth of Micro, Small and Medium size businesses…
Sabinsa / Sami labs recognized for export excellence by karnataka government trade promotion centre
Sabinsa Corp’s parent company Sami Labs was recognized with the Platinum Distinction Special Recognition Award by the Visvesvaraya Trade Promotion Centre (VTPC), Government of Karnataka Organization…
Sabinsa Europe and Healthspan Ltd. enter into Curcumin C3 Complex® supply agreement
Sabinsa Europe GmbH announced that it has entered into an agreement, on undisclosed terms and conditions, with Healthspan Limited, Guernsey, for the supply of Curcumin C3 Complex® DC…
Sami/Sabinsa sponsors ayurveda medical association national cancer treatment seminar: Ayurcan
Sabinsa’s SamiDirect India division was the lead sponsor of a two day National Seminar on Ayurvedic Oncology, Ayurcan, organized by the Ayurveda Medical Association of India (AMAI)…
Sabinsa Europe initiates legal proceedings against a former employee and a competitor, bioactives, for theft of customer database, financial data and proprietary sales information
Sabinsa Europe GmbH has taken legal action against a former employee and a competitor for alleged theft of proprietary customer lists, technical information and other data in defiance of German law…
New safety, stability and efficacy studies published on Sabinsa’s GRAS, shelf-stable probiotic LactoSpore®
Sabinsa’s shelf-stable LactoSpore® probiotic has been extensively researched in the 20 years since it was introduced, and recently several new studies, including clinical studies, have been published…
Sabinsa defends Tetrahydrocurcuminoids patent with legal action
Sabinsa Corp. has filed lawsuits in the United States District Court, District of New Jersey, against four dietary supplement ingredient companies for making, selling, and/or importing products that infringe upon Sabinsa’s Tetrahydrocurcuminoid Patent…
Resveratrol and Sabinsa’s BioPerine® on mitochondrial capacity with exercise
A recent human clinical study by the University of Georgia Department of Kinesiology in Athens, Georgia found that Resveratrol fortified with Sabinsa’s BioPerine® increases mitochondrial function…
Sabinsa announces curcumin testing program to assure authenticity in campaign to eliminate adulteration with synthetics
Sabinsa Corporation has taken another step in defending the purity of the curcumin supply chain with the addition of a conclusive test to guarantee that the range of Curcumin C3 Complex® products are all of natural origin…
Metabolic syndrome study on Sabinsa's Curcumin C3 Complex® honored with university research of the year award
A study that found benefits in metabolic syndrome patients given Sabinsa Corporation’s Curcumin C3 Complex® was chosen by a panel of experts for the NutraIngredients University Research of the Year Award, announced last week in Geneva, Switzerland…
Sabinsa received "No Questions" letter from US FDA on GRAS Status for LactoSpore®
Sabinsa Corporation has hit another important milestone for the shelf-stable probiotic LactoSpore® with receipt of a no questions letter on Generally Recognized As Safe (GRAS) status from the US FDA…
Sabinsa to feature LactoSpore® at New York society of Cosmetic Chemists Suppliers' Day - Booth # 1246
Sabinsa’s scientists will be available in booth #1246 to discuss in detail the science behind the company’s cutting edge ingredients, with particular emphasis on the popular shelf-stable probiotic LactoSpore®…
Sabinsa to feature LactoSpore®, Sabeet® and Curcumin Uc3 Clear™ at Vitafoods - Stand #: H21
Sabinsa will exhibit the company’s proprietary Ayurvedic-based natural nutraceutical ingredients, with a rich traditional history standardized for modern applications, at the VitaFoods tradeshow May 10th - 12th, 2016, in Geneva, Switzerland…
Sabinsa on wheels science summit in Germany hosts key customers and industry experts
Sabinsa Europe GmbH hosted Sabinsa on Wheels, a day-long science summit on Zugspitze, the highest mountain in Germany, on Wednesday March 16, 2016. In addition to presenting the latest clinical studies…
Sabinsa founder Dr. Muhammed Majeed honored as Industry Legend
Sabinsa founder Muhammed Majeed Ph.D. was honored for his pioneering role in building the nutraceuticals industry when he was inducted into the Hall Of Legends at Natural Products Expo West on Friday March 11, 2016 in Anaheim California…
Sabinsa founder Dr. Majeed honored with Global Innovation & Excellence Award for 110 patents, 15 patents recently added
Sabinsa Corporation founder Muhammed Majeed Ph.D. was honored with the NIB Global Innovation & Excellence Award at a ceremony organized by the Public Relations Council of India(PRCI) and the Press Club of India on February 20, 2016…
Stability research published on Sabinsa's LactoSpore® shelf stable probiotic for functional foods
With probiotics increasingly included in functional foods, demonstrating stability, and therefore viability, under processing and storage conditions becomes vital. To that end, Evaluation of the stability of Bacillus coagulans MTCC 5856 during processing and storage of functional foods…
Sabinsa publishes ForsLean® safety data in International Journal of Pharmacy & Pharmaceutical Research
Sabinsa Corporation and Sami Labs founder Dr. Muhammed Majeed was lead author of a paper published on the cumulative safety data of ForsLean®, the company’s patented coleus forskohlii extract…